Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Biorxiv : the Preprint Server for Biology|August 2, 2024
Convergent expansions of keystone gene families drive metabolic innovation in a major eukaryotic cladeKyle T David, Joshua G Schraiber, Johnathan G Crandall, et al.
Haematologica|June 13, 2015
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosisAlessandro M Vannucchi, Hagop M Kantarjian, Jean-Jacques Kiladjian, et al.
Blood Cancer Journal|November 24, 2025
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosisMonia Marchetti, Alessandro Maria Vannucchi, John O Mascarenhas, et al.
Hemasphere|August 27, 2025
Mesenchymal stromal cells from JAK2 V617F myeloproliferative neoplasms support healthy and malignant hematopoiesis in a humanized scaffold model in vivoAlessandra Ferrelli, Syed Mian, Marion Piganeau, et al.
Blood|January 21, 2014
Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohortsFrancesco Passamonti, Margherita Maffioli, Francisco Cervantes, et al.
Blood Neoplasia|June 2, 2025
Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal responseNaveen Pemmaraju, Tim C P Somervaille, Francesca Palandri, et al.
The Lancet. Haematology|March 31, 2022
Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendationsMonia Marchetti, Alessandro Maria Vannucchi, Martin Griesshammer, et al.
Leukemia Research|March 3, 2009
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosisRuben A Mesa, Susan Schwager, Deepti Radia, et al.
Haematologica|October 30, 2020
Recapitulation of erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalitiesCaroline Scott, Damien J Downes, Jill M Brown, et al.
Blood|January 25, 2014
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II studyPaola Guglielmelli, Flavia Biamonte, Giada Rotunno, et al.
Pageof 17